Gland Pharma Limited (BOM:543245)
India · Delayed Price · Currency is INR 3,047.30
+85.75 (2.90%)
At close: Oct 28, 2026
Gland Pharma Market Cap
Gland Pharma has a market cap or net worth of 502.98 billion as of October 28, 2026. Its market cap has increased by 59.16% in one year.
Market Cap
502.98B
Enterprise Value
472.23B
Revenue
67.25B
Global Rank
n/a
Country Rank
n/a
PE Ratio
44.54
ChartMarket Cap Chart
Since November 20, 2020, Gland Pharma's market cap has increased from 297.10B to 502.98B, an increase of 69.30%. That is a compound annual growth rate of 9.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 502.98B | 77.29% |
| Dec 31, 2025 | 283.71B | -3.22% |
| Dec 31, 2024 | 293.15B | -7.51% |
| Dec 29, 2023 | 316.97B | 22.08% |
| Dec 30, 2022 | 259.64B | -59.11% |
| Dec 31, 2021 | 634.96B | 66.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cipla | 1.09T |
| Mankind Pharma | 954.85B |
| Aurobindo Pharma | 914.85B |
| Glenmark Pharmaceuticals | 628.12B |
| Alkem Laboratories | 601.41B |
| Ipca Laboratories | 491.83B |
| Gland Pharma | 469.15B |
| Ajanta Pharma | 422.41B |